Trishula Therapeutics

0 followers


Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.

Industries

Headquarters

Stage

Employees

Links

Org chart

Anil Singhal
President & CEO

Anil Singhal

Collapse
Alan Luk
VP, CMC
Anh Tran
Head of Clinical Operations
Siddhartha Mitra
Chief Medical Officer
Mukesh K
Sr Clinical Data Manager
Thomas Mueller
Vice President, Head Of Immuno-oncology And Translational Sciences